Bank OZK acquired a new position in The Allstate Corporation (NYSE:ALL - Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 6,114 shares of the insurance provider's stock, valued at approximately $1,455,000.
A number of other institutional investors and hedge funds have also recently modified their holdings of the company. MV Capital Management Inc. acquired a new stake in shares of Allstate in the fourth quarter worth $25,000. Gables Capital Management Inc. acquired a new position in Allstate during the second quarter valued at $26,000. Navalign LLC acquired a new position in Allstate during the fourth quarter valued at $27,000. Kelleher Financial Advisors purchased a new stake in Allstate in the second quarter valued at $28,000. Finally, Evolution Wealth Management Inc. boosted its holdings in Allstate by 7,000.0% in the first quarter. Evolution Wealth Management Inc. now owns 142 shares of the insurance provider's stock valued at $29,000 after purchasing an additional 140 shares during the last quarter. Institutional investors and hedge funds own 76.47% of the company's stock.
Insider Buying and Selling at Allstate
In related news, COO Mario Rizzo sold 56,225 shares of the company's stock in a transaction dated Tuesday, August 11th. The shares were sold at an average price of $264.48, for a total transaction of $14,870,388.00. Following the completion of the transaction, the chief operating officer owned 82,227 shares in the company, valued at $21,747,396.96. This represents a 40.61% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider John E. Dugenske sold 32,996 shares of the company's stock in a transaction dated Friday, August 7th. The stock was sold at an average price of $269.33, for a total transaction of $8,886,812.68. Following the transaction, the insider owned 13,054 shares of the company's stock, valued at approximately $3,515,833.82. This trade represents a 71.65% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 91,446 shares of company stock valued at $24,208,675 over the last ninety days. Corporate insiders own 1.55% of the company's stock.
Allstate Stock Down 1.7%
Allstate stock opened at $257.24 on Friday. The company has a debt-to-equity ratio of 0.24, a current ratio of 0.36 and a quick ratio of 0.36. The stock has a market capitalization of $65.05 billion, a PE ratio of 5.14, a price-to-earnings-growth ratio of 0.40 and a beta of 0.16. The business has a 50 day simple moving average of $253.33 and a 200-day simple moving average of $226.56. The Allstate Corporation has a 12 month low of $188.08 and a 12 month high of $277.22.
Allstate (NYSE:ALL - Get Free Report) last announced its earnings results on Wednesday, August 5th. The insurance provider reported $8.99 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $6.06 by $2.93. Allstate had a return on equity of 41.64% and a net margin of 18.97%.The firm had revenue of $18.60 billion for the quarter, compared to analyst estimates of $15.46 billion. During the same quarter last year, the firm posted $5.94 EPS. The business's revenue was up 11.8% on a year-over-year basis. On average, analysts anticipate that The Allstate Corporation will post 34.45 EPS for the current fiscal year.
Allstate Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Thursday, October 1st. Shareholders of record on Monday, August 31st will be issued a dividend of $1.08 per share. This represents a $4.32 annualized dividend and a yield of 1.7%. The ex-dividend date of this dividend is Monday, August 31st. Allstate's dividend payout ratio (DPR) is presently 8.63%.
Wall Street Analyst Weigh In
Several equities analysts have recently issued reports on ALL shares. Roth Capital set a $300.00 price objective on Allstate in a report on Thursday, August 6th. Mizuho raised their target price on Allstate from $255.00 to $272.00 and gave the stock an "outperform" rating in a report on Thursday, July 9th. Weiss Ratings cut Allstate from a "buy (a)" rating to a "buy (a-)" rating in a research report on Tuesday. Keefe, Bruyette & Woods reissued an "underperform" rating and issued a $250.00 price target (down from $255.00) on shares of Allstate in a report on Thursday, August 20th. Finally, Barclays upped their price objective on Allstate from $213.00 to $226.00 and gave the stock an "underweight" rating in a research report on Thursday, August 6th. Four investment analysts have rated the stock with a Strong Buy rating, five have given a Buy rating, eight have given a Hold rating and four have assigned a Sell rating to the company. According to data from MarketBeat.com, Allstate has an average rating of "Hold" and a consensus target price of $265.26.
Read Our Latest Report on ALL
About Allstate
(
Free Report)
Allstate Corporation is a publicly traded insurance company headquartered in Northbrook, Illinois, and is one of the largest personal lines property and casualty insurers in the United States. Founded in 1931 as a subsidiary of Sears, Roebuck and Co, Allstate has grown into a diversified insurer that serves millions of consumers and businesses through a mix of distribution channels and product offerings.
The company underwrites a broad range of insurance products, with primary emphasis on auto and homeowners coverage.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Allstate, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Allstate wasn't on the list.
While Allstate currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.
This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.